Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Encapsulated Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Encapsulated Neoplasm

Cancer Family

Encapsulated Neoplasm

CI-CAN-00000014Explore in graph →

Non-malignant9 active trials6 evidence items

NCIt: C36035

Overview
Statistics
Survival
Genomics
Variants & evidence6
Drugs1
Trials60
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (5)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 1–5 of 5 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
· Thyroid · 2012 · PMID 22650231 · validated civic_curation pubmed
RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
· J Clin Endocrinol Metab · 2003 · PMID 12727991 · validated civic_curation pubmed
Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization.
· Mol Cell Endocrinol · 2015 · PMID 25448848 · validated civic_curation pubmed
Follicular thyroid carcinoma with NRAS Q61K and GNAS R201H mutations that had a good (131)I treatment response.
· Endocrinol Diabetes Metab Case Rep · 2016 · PMID 26788326 · validated civic_curation pubmed
MEN1 mutations in Hürthle cell (oncocytic) thyroid carcinoma.
· J Clin Endocrinol Metab · 2015 · PMID 25625803 · validated civic_curation pubmed

Showing 1–5 of 5 publications